| 臺大學術典藏 |
2022-09-15T01:09:59Z |
A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer
|
Chia-Chi Lin; Hsu C.-H.; Chen J.; Tsai T.-C.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:58Z |
Changing trends of prostate cancer in Asia
|
Pu Y.-S.; Chiang H.-S.; Chia-Chi Lin; Huang C.-Y.; Huang K.-H.; Chen J. |
| 臺大學術典藏 |
2022-09-15T01:09:58Z |
Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide
|
Hour T.-C.; Huang C.-Y.; Chia-Chi Lin; Chen J.; Guan J.-Y.; Lee J.-M.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:57Z |
Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer
|
Hour T.-C.; Pu Y.-S.; Chia-Chi Lin; Huang S.-W.; Chen J.; Chiu A.W.; Chen C.-J.; Huang C.-Y. |
| 臺大學術典藏 |
2022-09-15T01:09:57Z |
Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells
|
Pu Y.-S.; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; Huang C.-Y.; Chia-Chi Lin; Guan J.-Y.; Lin S.-R.; Hour T.-C. |
| 臺大學術典藏 |
2022-09-15T01:09:56Z |
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity
|
Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:56Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:56Z |
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study
|
Chia-Chi Lin; Hsu C.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:54Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:54Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:53Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Chia-Chi Lin; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; Huang C.-Y.; Huang K.-H.; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:52Z |
Systemic therapy for metastatic urothelial carcinoma
|
Chia-Chi Lin; Hsu C.-H.; Pu Y.-S.; Vogelzang N.J. |
| 臺大學術典藏 |
2022-09-15T01:09:51Z |
Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma
|
Chia-Chi Lin; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; Cheng A.-L.; Yang C.-H. |
| 臺大學術典藏 |
2022-09-15T01:09:51Z |
Down-regulated expression of RhoA in human conventional renal cell carcinoma
|
Pu Y.-S.; Wang C.-W.; Liu G.-Y.; Kuo Y.-Z.; Huang C.-Y.; Kang W.-Y.; Shun C.-T.; Chia-Chi Lin; Wu W.-J.; Hour T.-C. |
| 臺大學術典藏 |
2022-09-15T01:09:04Z |
Nuclear factor-κB overexpression is correlated with poor outcomes after multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer
|
Chiang Y.; Wang C.-C.; Tsai Y.-C.; Huang C.-Y.; Pu Y.-S.; Chia-Chi Lin; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-09-06T08:56:53Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2022-07-12T01:43:17Z |
Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: A retrospective study of 1875 cases in Taiwan
|
Chiang I.-N.; SHANG-JEN CHANG; Pu Y.-S.; Huang K.-H.; Yu H.-J.; Huang C.-Y. |
| 臺大學術典藏 |
2022-07-12T01:43:14Z |
Comparison of 6- and 12-core prostate biopsy in Taiwanese men: Impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection
|
Chiang I.-N.; SHANG-JEN CHANG; Pu Y.-S.; Huang K.-H.; Yu H.-J.; Huang C.-Y. |
| 臺大學術典藏 |
2022-07-12T01:43:13Z |
Diagnostic Value of Finger-guided Prostate Nodule Biopsy Combined With Systemic Random Biopsy
|
Chiang I.-N.; SHANG-JEN CHANG; Pu Y.-S.; Huang K.-H.; Yu H.-J.; Huang C.-Y. |
| 臺大學術典藏 |
2022-05-10T08:09:52Z |
Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: Systematic review and network meta-analysis
|
Huang S.-W.; Tsai C.-Y.; Tseng C.-S.; Shih M.-C.; Yeh Y.-C.; Chien K.-L.; Pu Y.-S.; YU-KANG TU |
| 臺大學術典藏 |
2022-05-09T06:25:43Z |
Extranodal extension predicts poor survival outcomes among patients with bladder cancer
|
Liao Y.-A.; Chiang C.-J.; WEN-CHUNG LEE; Zhuang B.-Z.; Chen C.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2022-05-05T08:48:55Z |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; CHIA-CHUN WANG; Lan K.-H.; Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-05-05T08:48:55Z |
Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
|
Hou W.-H.; Huang C.-Y.; CHIA-CHUN WANG; Lan K.-H.; Chen C.-H.; Yu H.-J.; Liu S.-P.; Lai M.-K.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-05-05T08:48:55Z |
Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; CHIA-CHUN WANG; Lan K.-H.; Yu H.-J.; Lai M.-K.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-05-05T08:48:54Z |
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma
|
Hsu F.-M.; Hou W.-H.; Huang C.-Y.; CHIA-CHUN WANG; Tsai C.-L.; Tsai Y.-C.; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-04-28T12:31:28Z |
Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: Systematic review and network meta-analysis
|
Huang S.-W.; Tsai C.-Y.; Tseng C.-S.; Shih M.-C.; Yeh Y.-C.; KUO-LIONG CHIEN; Pu Y.-S.; Tu Y.-K. |
| 臺大學術典藏 |
2022-04-20T08:12:05Z |
Extranodal extension predicts poor survival outcomes among patients with bladder cancer
|
Liao Y.-A.; CHUN-JU CHIANG; Lee W.-C.; Zhuang B.-Z.; Chen C.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2022-03-31T02:39:09Z |
Increased upper and lower tract Urothelial carcinoma in patients with end-stage renal disease: A nationwide cohort study in Taiwan during 1997-2008
|
Wang S.-M.; Lai M.-N.; PAU-CHUNG CHEN; Pu Y.-S.; Lai M.-K.; Hwang J.-S.; Wang J.-D. |
| 臺大學術典藏 |
2022-03-31T02:39:06Z |
Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid
|
Wang S.-M.; Lai M.-N.; Wei A.; Chen Y.-Y.; Pu Y.-S.; PAU-CHUNG CHEN; Wang J.-D. |
| 臺大學術典藏 |
2022-03-31T02:38:48Z |
Aristolochic acid in the etiology of renal cell carcinoma
|
Hoang M.L.; Chen C.-H.; PAU-CHUNG CHEN; Roberts N.J.; Dickman K.G.; Yun B.H.; Turesky R.J.; Pu Y.-S.; Vogelstein B.; Papadopoulos N.; Grollman A.P.; Kinzler K.W.; Rosenquist T.A. |
| 臺大學術典藏 |
2022-03-04T03:48:41Z |
Clinical and pathological data of 10 malignant pheochromocytomas: Long-term follow up in a single institute
|
Huang K.-H.; Chung S.-D.; Chen S.-C.; Chueh S.-C.; Pu Y.-S.; Lai M.-K.; WEI-CHOU LIN |
| 臺大學術典藏 |
2022-03-04T03:48:36Z |
Primary Mucinous Adenocarcinoma of Renal Pelvis with Carcinoembryonic Antigen Production
|
Ho C.-H.; WEI-CHOU LIN; Pu Y.-S.; Yu H.-J.; Huang C.-Y. |
| 臺大學術典藏 |
2022-03-04T03:48:35Z |
The Role of Lymphovascular Invasion in Predicting the Prognosis of Clinically Localized Upper Tract Urothelial Carcinoma (pT1-3cN0M0)
|
WEI-CHOU LIN; Hu F.-C.; Chung S.-D.; Chueh S.-C.; Pu Y.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:31Z |
Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors
|
Ho C.-H.; Huang C.-Y.; WEI-CHOU LIN; Chueh S.-C.; Pu Y.-S.; Lai M.-K.; Yu H.-J.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:30Z |
Expression of Stathmin in Localized Upper Urinary Tract Urothelial Carcinoma: Correlations With Prognosis
|
WEI-CHOU LIN; Chen S.-C.; Hu F.-C.; Chueh S.-C.; Pu Y.-S.; Yu H.-J.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:28Z |
An Unusual Presentation of Prostate Adenocarcinoma Metastatic to the Oral Cavity
|
Weng W.-C.; WEI-CHOU LIN; Pu Y.-S.; Yu H.-J.; Huang C.-Y. |
| 臺大學術典藏 |
2022-03-04T03:48:22Z |
2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells
|
Kuo K.-L.; WEI-CHOU LIN; Ho I.-L.; Chang H.-C.; Lee P.-Y.; Chung Y.-T.; Hsieh J.-T.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:21Z |
Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells
|
Huang K.-H.; Kuo K.-L.; Ho I.-L.; Chang H.-C.; Chuang Y.-T.; WEI-CHOU LIN; Lee P.-Y.; Chang S.-C.; Chiang C.-K.; Pu Y.-S.; Chou C.-T.; Hsu C.-H.; Liu S.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:19Z |
Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma
|
Hu C.-Y.; Tsai Y.-C.; Wang S.-M.; Huang C.-Y.; Tai H.-C.; Chen C.-H.; Pu Y.-S.; WEI-CHOU LIN; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:18Z |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; WEI-CHOU LIN; Tsai Y.-C.; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:18Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
WEI-CHOU LIN; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C.; Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; Liu S.-H.; Jeng Y.-M.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:16Z |
MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma
|
Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; WEI-CHOU LIN; Tsai Y.-C.; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:15Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lien C.-C.; Liu K.-L.; Chow P.-M.; WEI-CHOU LIN; Tai H.-C.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2022-03-04T03:48:14Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lien C.-C.; Liu K.-L.; Chou P.-M.; WEI-CHOU LIN; Tai H.-C.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2022-01-25T05:10:35Z |
Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7
|
Hsu Y.-H.; Lin W.-L.; Hou Y.-T.; Pu Y.-S.; Shun C.-T.; CHI-LING CHEN; Wu Y.-Y.; Chen J.-Y.; Chen T.-H.; Jou T.-S. |
| 臺大學術典藏 |
2022-01-17T08:00:28Z |
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
|
Chen C.-H.; Dickman K.G.; Huang C.-Y.; Moriya M.; Shun C.-T.; Tai H.-C.; Huang K.-H.; Wang S.-M.; YUAN-JU LEE; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2022-01-17T08:00:26Z |
Metallic ureteral stents in malignant ureteral obstruction: Clinical factors predicting stent failure
|
Chow P.-M.; Hsu J.-S.; Huang C.-Y.; Wang S.-M.; YUAN-JU LEE; Huang K.-H.; Yu H.-J.; Pu Y.-S.; Liang P.-C. |
| 臺大學術典藏 |
2022-01-17T08:00:25Z |
Paragangliomas of the urinary bladder: A report of 6 cases and review of the literature
|
Chang Y.-K.; Chiang I.-N.; Chen C.-H.; Wang S.-M.; YUAN-JU LEE; Pu Y.-S.; Huang C.-Y. |
| 臺大學術典藏 |
2022-01-17T08:00:25Z |
Malignant ureteral obstruction: Functional duration of metallic versus polymeric ureteral stents
|
Chow P.-M.; Chiang I.-N.; Chen C.-Y.; Huang K.-H.; Hsu J.-S.; Wang S.-M.; YUAN-JU LEE; Yu H.-J.; Pu Y.-S.; Huang C.-Y. |
| 臺大學術典藏 |
2022-01-17T08:00:24Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; YUAN-JU LEE; Chow P.-M.; Hung S.-C.; Huang C.-Y. |
